Correlation of Gene Status and Clinical Outcomes in ESCC
NCT03831828 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2019-02-08
Summary
The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.
Conditions
- Prognosis of Patients With ESCC
Sponsors & Collaborators
-
OrigiMed
collaborator INDUSTRY -
LiuJunFeng
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-26
- Primary Completion
- 2019-04-01
- Completion
- 2019-04-01
Countries
- China
Study Locations
More Related Trials
-
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
NCT06490003 ·Status: RECRUITING
-
Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy
NCT06169930 ·Status: COMPLETED
-
Genome-wide Association Study
NCT01498757 ·Status: WITHDRAWN
-
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
NCT03160209 ·Status: COMPLETED
-
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
NCT00628368 ·Status: COMPLETED ·Phase: NA
-
Prediction Model of Response for CCRT in Esophageal Cancer
NCT03081988 ·Status: RECRUITING
-
Esophageal Cancer Genetics Studies
NCT00341276 ·Status: COMPLETED
-
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NCT05807542 ·Status: COMPLETED ·Phase: PHASE2
-
ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma
NCT05426850 ·Status: UNKNOWN
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
NCT06241066 ·Status: COMPLETED
-
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）
NCT06828718 ·Status: ACTIVE_NOT_RECRUITING
-
Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery
NCT00898495 ·Status: COMPLETED
-
Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor
NCT07152535 ·Status: NOT_YET_RECRUITING
-
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 ·Status: NOT_YET_RECRUITING
-
Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer
NCT03029793 ·Status: UNKNOWN
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Outcomes of Esophageal Cancer
NCT05177393 ·Status: RECRUITING
-
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC
NCT04759235 ·Status: UNKNOWN
-
Retrospective Review of Esophageal Cancer at MSKCC
NCT05706558 ·Status: RECRUITING
-
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
NCT04207918 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
NCT06601309 ·Status: RECRUITING ·Phase: PHASE2
-
Follow-up Strategy for Esophageal Cancer Patients
NCT06045715 ·Status: UNKNOWN
-
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
NCT01822613 ·Status: COMPLETED ·Phase: PHASE1